Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740219 · ClinicalTrials.gov registry record · NA

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
348
Enrollment target

NCT01740219 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 348 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740219, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
348 participants
Enrollment target

Study Summary

This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.

Interventions

  • BEHAVIORAL Capacity Enhancement
  • BEHAVIORAL Standard Dissemination

Trial Details

FieldValue
Enrollment Target 348 participants
Start Date 2011-09
Est. Completion 2013-09
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT01740219

The ClinicalTrials.gov registry entry for NCT01740219 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 348 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Capacity Enhancement is the first listed.

NCT01740219 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01740219 about?

NCT01740219 is a clinical study titled "Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches". This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly pr...

What is the current status of trial NCT01740219?

This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2011-09. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01740219?

The interventions under investigation include: Capacity Enhancement (BEHAVIORAL), Standard Dissemination (BEHAVIORAL).

Who is sponsoring clinical trial NCT01740219?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.